JAMA Network Home
Sign In
Review

Ovarian Cancer

JAMA 10.1001/jama.2025.9495

July 21, 2025 at 11:00 AM EDT

Read the full article

Approximately 21 000 women are diagnosed with ovarian cancer annually in the US, and approximately 80% have advanced-stage ovarian cancer at diagnosis. First-line treatment of early-stage ovarian cancer is surgery and adjuvant platinum-based chemotherapy. Treatment of advanced-stage ovarian cancer includes cytoreductive surgery, platinum-based chemotherapy, and targeted maintenance therapies such as bevacizumab and/or PARP inhibitors.

Corresponding Author: William Cliby, MD, Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (cliby.william@mayo.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.9495?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072125

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks